OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Renren Bai, Jianan Guo, Xiang‐Yang Ye, et al.
Ageing Research Reviews (2022) Vol. 77, pp. 101619-101619
Closed Access | Times Cited: 411

Showing 1-25 of 411 citing articles:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114

Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer’s Disease: Role of Glutathione and Metal Ions
Rimil Guha Roy, Pravat K. Mandal, Joseph C. Maroon
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 17, pp. 2944-2954
Open Access | Times Cited: 70

Oxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics
Rishika Dhapola, Samir Kumar Beura, Prajjwal Sharma, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 62

Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review
Zhao Da, Kailin Yang, Hua Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114312-114312
Open Access | Times Cited: 46

An NIR-Driven Upconversion/C3N4/CoP Photocatalyst for Efficient Hydrogen Production by Inhibiting Electron–Hole Pair Recombination for Alzheimer’s Disease Therapy
Kezhen Ge, Zheng Li, Ali Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 3, pp. 2222-2234
Closed Access | Times Cited: 43

Customized Intranasal Hydrogel Delivering Methylene Blue Ameliorates Cognitive Dysfunction against Alzheimer's Disease
Yujing Liu, Yun Tan, Guopan Cheng, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 30

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 17

Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management
Jinjin Pei, Ranil Vikraman Kumarasamy, Selvaraj Jayaraman, et al.
Ageing Research Reviews (2025), pp. 102665-102665
Closed Access | Times Cited: 3

Plant-derived nanovesicles: Further exploration of biomedical function and application potential
Aixue Li, Dan Li, Yongwei Gu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3300-3320
Open Access | Times Cited: 36

Advance in the pharmacological effects of quercetin in modulating oxidative stress and inflammation related disorders
Yueke Zhou, Cheng Qian, Yu Tang, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4999-5016
Open Access | Times Cited: 31

Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding
William B. Grant, Steven M. Blake
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1353-1382
Open Access | Times Cited: 25

Oxygen metabolism abnormality and Alzheimer's disease: An update
Guangdong Liu, Cui Yang, Xin Wang, et al.
Redox Biology (2023) Vol. 68, pp. 102955-102955
Open Access | Times Cited: 25

Recent progress of oxidative stress associated biomarker detection
Jinɡjinɡ Li, Limeng Pan, Wei Pan, et al.
Chemical Communications (2023) Vol. 59, Iss. 48, pp. 7361-7374
Closed Access | Times Cited: 23

Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)
Pei Qin, Ye Sun, Liya Li
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 5
Open Access | Times Cited: 15

Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 13

PEGylated-liposomal astaxanthin ameliorates Aβ neurotoxicity and Alzheimer-related phenotypes by scavenging formaldehyde
Ziqi Gu, Hang Zhao, Yilan Song, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 783-797
Open Access | Times Cited: 12

Cerebellum in Alzheimer's disease and other neurodegenerative diseases: an emerging research frontier
Cui Yang, Guangdong Liu, Xi Chen, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 11

Melatonin: A potential nighttime guardian against Alzheimer’s
Z Zhang, Pei Xue, Barbara B. Bendlin, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 11

Quercetin-derived red emission carbon dots: A multifunctional theranostic nano-agent against Alzheimer’s β-amyloid fibrillogenesis
Zitong Wei, Xiaoyan Dong, Yan Sun
Colloids and Surfaces B Biointerfaces (2024) Vol. 238, pp. 113907-113907
Closed Access | Times Cited: 10

Therapeutic potential of the medicinal mushroom Ganoderma lucidum against Alzheimer's disease
Xu-Jia Chen, Zhou Deng, Lele Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116222-116222
Open Access | Times Cited: 9

Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease
Jordan P. Hickey, Andrila E. Collins, Mackayla L. Nelson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4379-4402
Open Access | Times Cited: 9

Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer’s disease
Liding Zhang, Kai Cao, Jun Xie, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9

Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer’s Disease
Raghuraj Singh, Archna Panghal, Krishna Jadhav, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10916-10940
Closed Access | Times Cited: 9

Protective effect of flavonoids on oxidative stress injury in Alzheimer’s disease
Kaixuan Wang, Xinmei Chen
Natural Product Research (2024), pp. 1-28
Closed Access | Times Cited: 9

Page 1 - Next Page

Scroll to top